id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338729-v2suoj3c	Streicher, Caroline	Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report	2020-09-20		.txt	text/plain	1629	100	47	Indeed, the first Chinese and Italian data suggest that tocilizumab could be an efficient treatment for patients with severe COVID-19 and CRS. Recently, there have been an increased number of studies on the use of tocilizumab treatment for severe COVID-19 patients, but more information is needed on its effectiveness and safety, notably for the treatment of elderly patients. In this case, we describe the successful treatment by tocilizumab of an 87-year-old patient with severe COVID-19. Results show that tocilizumab significantly improves the prognosis of patients and confirm the benefit of tocilizumab for the treatment of moderate and severe COVID-19 patients [16] . However, to our knowledge, it is the first case report that describes the use of tocilizumab in a patient aged > 80 years with severe COVID-19. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality Effective treatment of severe COVID-19 patients with tocilizumab	./cache/cord-338729-v2suoj3c.txt	./txt/cord-338729-v2suoj3c.txt